FDA Approves SUCCINYLCHOLINE CHLORIDE — STERISCIENCE SPECIALTIES PRIVATE LIMITED

STERISciENCE Specialties Private Limited announced today that the FDA has granted approval for its Abbreviated New Drug Application (#ANDA217873) for Succinylcholine Chloride Intramuscular injectable. This clearance is expected to address current supply shortages and expand pricing options in the volatile intensive care drug market.